ERIS Lifesciences Ltd (ERIS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002771, "name": "ERIS Lifescience", "stock_name": "ERIS Lifescience", "full_name": "ERIS Lifesciences Ltd", "name_url": "stocks-analysis/eris-lifescience", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "1,383.40", "chg": -1.9, "chgp": "-0.14%", "dir": -1, "prev_price": "1,385.30", "mcapval": "19,061.00 Cr", "mcap": "Small Cap", "scripcode": 540596, "symbol": "ERIS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE406M01024", "curr_date": "Feb 02", "curr_time": "", "bse_nse_vol": "42.72 k", "exc_status": "Active", "traded_date": "Feb 02, 2026", "traded_date_str": "2026 02 02", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eris-lifescience-1002771-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "ERIS Lifesciences Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-ltd-is-rated-sell-3812418", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ERISLifescience_mojoScore_3812418.png", "date": "2026-01-31 10:10:48", "description": "ERIS Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 January 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "ERIS Lifesciences Downgraded to Sell Amid Bearish Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-downgraded-to-sell-amid-bearish-technicals-and-valuation-concerns-3795501", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ERISLifescience_mojoScore_3795501.png", "date": "2026-01-20 08:27:22", "description": "ERIS Lifesciences Ltd has seen its investment rating downgraded from Hold to Sell as of 19 Jan 2026, driven primarily by deteriorating technical indicators and valuation concerns despite solid financial performance. The company’s Mojo Score has declined to 44.0, reflecting a shift in market sentiment and caution among investors." }, { "title": "ERIS Lifesciences Ltd Upgraded to Hold on Improved Technicals and Solid Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-ltd-upgraded-to-hold-on-improved-technicals-and-solid-financials-3791489", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ERISLifescience_mojoScore_3791489.png", "date": "2026-01-14 08:15:53", "description": "ERIS Lifesciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This recalibration follows a detailed assessment of the company’s recent performance, market positioning, and comparative returns, signalling cautious optimism among analysts and investors alike." }, { "title": "ERIS Lifesciences Ltd: Technical Momentum Shifts Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-ltd-technical-momentum-shifts-amid-mixed-indicators-3791386", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ERISLifescience_technicaldot_3791386.png", "date": "2026-01-14 08:03:24", "description": "ERIS Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a recent downgrade in daily moving averages and a 1.58% decline in share price, the stock’s longer-term metrics suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "ERIS Lifesciences Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-ltd-is-rated-sell-3788738", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ERISLifescience_mojoScore_3788738.png", "date": "2026-01-11 10:10:39", "description": "ERIS Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 11 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing." }, { "title": "ERIS Lifesciences Gains 0.72%: 3 Key Factors Driving the Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-gains-072-3-key-factors-driving-the-weeks-mixed-momentum-3779568", "imagepath": "", "date": "2026-01-03 13:15:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>29 Dec:</strong> Technical momentum shifts amid mixed market signals</p>\n <p><strong>31 Dec:</strong> Downgrade to Sell rating amid technical weakness and valuation concerns</p>\n <p><strong>31 Dec:</strong> Bearish momentum intensifies following technical downgrade</p>\n <p><strong>2 Jan:</strong> Stock rebounds to close at Rs.1,537.00 (+2.51%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,526.80</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div ..." }, { "title": "ERIS Lifesciences Downgraded to Sell Amid Technical Weakness and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3775815", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ERISLifescience_mojoScore_3775815.png", "date": "2025-12-31 08:14:49", "description": "ERIS Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 30 December 2025. This shift reflects a combination of deteriorating technical indicators, valuation pressures, and concerns over long-term financial growth despite recent positive quarterly results. The company’s current Mojo Score stands at 44.0, with a Sell grade, marking a notable change in market sentiment." }, { "title": "ERIS Lifesciences Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-ltd-faces-bearish-momentum-amid-technical-downgrade-3775744", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ERISLifescience_technicaldot_3775744.png", "date": "2025-12-31 08:12:23", "description": "ERIS Lifesciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The company’s stock price has declined by 1.41% on 31 Dec 2025, reflecting growing investor caution amid mixed technical signals and a recent downgrade in its Mojo Grade from Hold to Sell." }, { "title": "ERIS Lifesciences Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-ltd-is-rated-hold-by-marketsmojo-3773152", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ERISLifescience_mojoScore_3773152.png", "date": "2025-12-29 10:10:04", "description": "ERIS Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing." } ], "total": 287, "sid": "1002771", "stock_news_url": "https://www.marketsmojo.com/news/eris-lifesciences-1002771" }, "announcements": [ { "details": "Eris Lifesciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Eris Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "05-Dec-2019" }, { "details": "Eris Lifesciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Eris Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "03-Dec-2019" }, { "details": "Eris Lifesciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Eris Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "28-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "ERIS Lifesciences Ltd has declared <strong>735%</strong> dividend, ex-date: 13 Feb 25", "dt": "2025-02-13", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

29 Dec: Technical momentum shifts amid mixed market signals

31 Dec: Downgrade to Sell rating amid technical weakness and valuation concerns

31 Dec: Bearish momentum intensifies following technical downgrade

2 Jan: Stock rebounds to close at Rs.1,537.00 (+2.51%)

Week Open

Rs.1,526.80

Week Close

Read full news article

ERIS Lifesciences Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2025-12-31 08:14:49

ERIS Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 30 December 2025. This shift reflects a combination of deteriorating technical indicators, valuation pressures, and concerns over long-term financial growth despite recent positive quarterly results. The company’s current Mojo Score stands at 44.0, with a Sell grade, marking a notable change in market sentiment.

Read full news article

ERIS Lifesciences Ltd Faces Bearish Momentum Amid Technical Downgrade

2025-12-31 08:12:23

ERIS Lifesciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The company’s stock price has declined by 1.41% on 31 Dec 2025, reflecting growing investor caution amid mixed technical signals and a recent downgrade in its Mojo Grade from Hold to Sell.

Read full news article

ERIS Lifesciences Ltd is Rated Hold by MarketsMOJO

2025-12-29 10:10:04

ERIS Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article